FDA will drop two-study requirement for new drug approvals, aiming to speed access
Source: The Washington Times stories: Politics · Bias: Center Right
Summary
The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval for new drugs, the latest change from Trump administration officials vowing to speed up the availability of certain medical products.
Related Coverage
- Taylor Swift and Travis Kelce married at New York City’s Madison Square Garden (Center Left — US news | The Guardian)
- Trump announces new pardons after privately weighing "Diddy" clemency, sources said (Center — Politics - CBSNews.com)
- Business Leader Calls on New York City to Resist Mamdani (Far Right — The Gateway Pundit)
- Luka Doncic weighs in on new-look Lakers roster amid heavy criticism (Right — New York Post)
- Pay-to-play cycle behind GOP's corporate tax cuts exposed in new report (Far Left — Raw Story)
- Mamdani mocked by GOP for telling New Yorkers to set thermostats to 78 (Center — The Hill News)
- READ IN FULL: Zohran Mamdani’s America 250 address from George Washington’s desk at New York City Hall (Center Right — Washington Examiner)
- Mamdani Is Telling A Brazen Lie About ‘Capitalist Mismanagement’ Of New York (Far Right — The Federalist)
More Headlines From February 18, 2026
- The canonization of Jesse Jackson (Center Right)
- Texas Election Season Heats Up as Early Voting in Senate Primaries Begins (Center Left)
- Telling clues revealed that US war imminent: '90% chance' (Far Left)
- Trump just gave the game away about his next military move (Far Left)
- Action demanded after new Epstein files point to 'crimes against humanity' (Left)






